Matthew J. Olnes

3.0k total citations
42 papers, 1.6k citations indexed

About

Matthew J. Olnes is a scholar working on Hematology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Matthew J. Olnes has authored 42 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 12 papers in Immunology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Matthew J. Olnes's work include Acute Myeloid Leukemia Research (16 papers), Hematopoietic Stem Cell Transplantation (12 papers) and Platelet Disorders and Treatments (5 papers). Matthew J. Olnes is often cited by papers focused on Acute Myeloid Leukemia Research (16 papers), Hematopoietic Stem Cell Transplantation (12 papers) and Platelet Disorders and Treatments (5 papers). Matthew J. Olnes collaborates with scholars based in United States, Brazil and Russia. Matthew J. Olnes's co-authors include Rodrigo Erlich, Neal S. Young, Phillip Scheinberg, Colin O. Wu, Ankur R. Parikh, Cynthia E. Dunbar, Ronan Desmond, Bogdan Dumitriu, Katherine R. Calvo and Angélique Biancotto and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

Matthew J. Olnes

39 papers receiving 1.6k citations

Peers

Matthew J. Olnes
David L. Becton United States
Massimo Iacobelli United States
Edward J. Fitzsimons United Kingdom
Michael Daskalakis Switzerland
Bruce R. Blazar United States
David L. Becton United States
Matthew J. Olnes
Citations per year, relative to Matthew J. Olnes Matthew J. Olnes (= 1×) peers David L. Becton

Countries citing papers authored by Matthew J. Olnes

Since Specialization
Citations

This map shows the geographic impact of Matthew J. Olnes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew J. Olnes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew J. Olnes more than expected).

Fields of papers citing papers by Matthew J. Olnes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew J. Olnes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew J. Olnes. The network helps show where Matthew J. Olnes may publish in the future.

Co-authorship network of co-authors of Matthew J. Olnes

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew J. Olnes. A scholar is included among the top collaborators of Matthew J. Olnes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew J. Olnes. Matthew J. Olnes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Olnes, Matthew J. & Holly Martinson. (2021). Recent advances in immune therapies for gastric cancer. Cancer Gene Therapy. 28(9). 924–934. 21 indexed citations
2.
Kapoor, Sargam, et al.. (2021). Thrombopoietin receptor agonists for marrow failure: A concise clinical review. Best Practice & Research Clinical Haematology. 34(2). 101274–101274. 1 indexed citations
3.
Kapoor, Sargam, et al.. (2021). Immune Therapies for Myelodysplastic Syndromes and Acute Myeloid Leukemia. Cancers. 13(19). 5026–5026. 7 indexed citations
4.
Nash, Sarah H., et al.. (2019). Invasive breast cancer among Alaska Native women in Alaska. International Journal of Circumpolar Health. 78(1). 1633190–1633190. 1 indexed citations
5.
Martinson, Holly, et al.. (2018). Gastric cancer in Alaska Native people: A cancer health disparity. World Journal of Gastroenterology. 24(25). 2722–2732. 15 indexed citations
6.
Zhao, Xin, Xingmin Feng, Zhijie Wu, et al.. (2017). Persistent elevation of plasma thrombopoietin levels after treatment in severe aplastic anemia. Experimental Hematology. 58. 39–43. 11 indexed citations
7.
Piromalli, Christopher, et al.. (2016). A09-C Offering ‘High-Tech, High Touch' Culturally Respectful Care: A Pilot Telepalliative Care Project in Rural Alaska. Journal of Pain and Symptom Management. 52(6). e11–e11. 1 indexed citations
8.
Olnes, Matthew J., Yuri Kotliarov, Angélique Biancotto, et al.. (2016). Effects of Systemically Administered Hydrocortisone on the Human Immunome. Scientific Reports. 6(1). 23002–23002. 122 indexed citations
9.
Biancotto, Angélique, Shira Perl, Matthew J. Olnes, et al.. (2013). Baseline Levels and Temporal Stability of 27 Multiplexed Serum Cytokine Concentrations in Healthy Subjects. PLoS ONE. 8(12). e76091–e76091. 84 indexed citations
10.
Olnes, Matthew J., Phillip Scheinberg, Katherine R. Calvo, et al.. (2012). Eltrombopag and Improved Hematopoiesis in Refractory Aplastic Anemia. New England Journal of Medicine. 367(1). 11–19. 345 indexed citations
11.
Olnes, Matthew J., Aarthi Shenoy, Barbara Weinstein, et al.. (2012). Directed therapy for patients with myelodysplastic syndromes (MDS) by suppression of cyclin D1 with ON 01910.Na. Leukemia Research. 36(8). 982–989. 32 indexed citations
12.
Parikh, Ankur R., Matthew J. Olnes, & A. John Barrett. (2012). Immunomodulatory Treatment of Myelodysplastic Syndromes: Antithymocyte Globulin, Cyclosporine, and Alemtuzumab. Seminars in Hematology. 49(4). 304–311. 30 indexed citations
13.
Olnes, Matthew J., Andrea Poon, Loretta Pfannes, et al.. (2011). Effects of granulocyte–colony‐stimulating factor on Monosomy 7 aneuploidy in healthy hematopoietic stem cell and granulocyte donors. Transfusion. 52(3). 537–541. 8 indexed citations
14.
Olnes, Matthew J.. (2011). Targeting Immune Dysregulation in Myelodysplastic Syndromes. JAMA. 305(8). 814–814. 43 indexed citations
15.
Parikh, Ankur R., Colin O. Wu, Andrea Poon, et al.. (2011). Immunosuppressive Treatment for Patients with Myelodysplastic Syndromes: A Review of 358 Patients. Blood. 118(21). 1717–1717.
16.
Jatiani, Shashi, Stephen C. Cosenza, M. V. Ramana Reddy, et al.. (2010). A Non-ATP-Competitive Dual Inhibitor of JAK2V617F and BCR-ABLT315I Kinases: Elucidation of a Novel Therapeutic Spectrum Based on Substrate Competitive Inhibition. Genes & Cancer. 1(4). 331–345. 27 indexed citations
17.
Olnes, Matthew J. & Rodrigo Erlich. (2004). A Review and Update on Cholangiocarcinoma. Oncology. 66(3). 167–179. 208 indexed citations
18.
Olnes, Matthew J., et al.. (2003). Hematologic Malignancies With Extramedullary Spread of Disease. Journal of Clinical Oncology. 21(9). 1890–1891. 1 indexed citations
19.
Verma, Mukesh, Susan Mathew, Rabinder N. Kurl, et al.. (1996). Promoter of the canine tracheobronchial mucin gene. Glycoconjugate Journal. 13(5). 797–807. 3 indexed citations
20.
Kurl, Rabinder N., Paolo B. DePetrillo, & Matthew J. Olnes. (1993). Inhibition of Ah (dioxin) receptor transformation by 9-hydroxy ellipticine. Biochemical Pharmacology. 46(8). 1425–1433. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026